Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula (left eye)
ICD-10 E09.3532 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula (left eye).
E09.3532 refers to diabetes mellitus that is induced by drugs or chemicals, leading to significant complications such as proliferative diabetic retinopathy (PDR) and traction retinal detachment in the left eye. Proliferative diabetic retinopathy is characterized by the growth of new blood vessels on the retina, which can lead to serious vision problems. In this case, the traction retinal detachment does not involve the macula, which is crucial for central vision. The condition arises from the effects of certain medications or toxins that disrupt normal glucose metabolism, leading to hyperglycemia and subsequent diabetic complications. Management of this condition often requires a multidisciplinary approach, including endocrinology for diabetes management and ophthalmology for retinal issues. Regular monitoring of HbA1c levels is essential to assess long-term glycemic control, and insulin therapy may be necessary to manage blood glucose levels effectively.
Comprehensive medication history, HbA1c levels, and management plans.
Patients presenting with new-onset diabetes due to medication, requiring insulin management.
Ensure clear documentation of the drug responsible for diabetes and its management.
Detailed retinal examination findings, imaging results, and treatment plans.
Patients with proliferative diabetic retinopathy requiring laser treatment or surgery.
Document the extent of retinal detachment and any interventions performed.
Used for treatment of proliferative diabetic retinopathy.
Document the extent of retinal damage and treatment rationale.
Ophthalmologists should document the specific areas treated.
Several classes of medications, including corticosteroids, antipsychotics, and certain chemotherapy agents, can induce diabetes by affecting insulin secretion or action.
